Erosive Esophagitis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Condition: Erosive Esophagitis Interventions: Drug: CJ-12420 100mg QD; Drug: Esomeprazole 40mg; Drug: CJ-12420 50mg QD Sponsor: CJ HealthCare Corporation Recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 14, 2016 Category: Research Source Type: clinical trials
